Aldosterone, not estradiol, is the physiological agonist for rapid increases in cAMP in vascular smooth muscle cells

Circulation

Volumn 99, Issue 11, 1999, Pages 1485-1491

  Christ, Michael ^a   Günther, Andreas ^a   Heck, Marina ^a   Schmidt, Bernhard M W ^a   Falkenstein, Elisabeth ^a   Wehling, Martin ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Hormones; Muscle, smooth; Pharmacology; Vasculature

Indexed keywords

ADENYLATE CYCLASE; ALDOSTERONE; CALCIUM; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLOHEXIMIDE; DACTINOMYCIN; ESTRADIOL; HYDROCORTISONE; ISOBUTYLMETHYLXANTHINE; ISOPRENALINE; MINERALOCORTICOID RECEPTOR; SPIRONOLACTONE; THAPSIGARGIN;

AGONIST; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; GENETIC TRANSCRIPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SMOOTH MUSCLE FIBER; SWINE; VASCULAR SMOOTH MUSCLE;

EID: 0344959523     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.11.1485     Document Type: Article

References (46)

1. Evans RM. The steroid and thyroid hormone receptor superfamily. Science. 1988;240:889-895.
2. Amero SA, Kretsinger RH, Moncrief ND, Yamamoto KR, Pearson WR. The origin of nuclear receptor proteins: a single precursor distinct from other transcription factors. Mol Endocrinol. 1983;6:3-7.
3. Payvar F, DeFranco D, Firestone GL, Edgar B, Wrange O, Okret S, Gustafsson JA, Yamamoto KR. Sequence-specific binding of glucocorticoid receptor to MTV DNA at sites within and upstream of the transcribed region. Cell. 1983;36:381-392.
4. Pearce D, Yamamoto KR. Mineralocorticoid and glucocorticoid receptor activities distinguished by nonreceptor factors at a composite response element. Science. 1993;259:1161-1165.
5. Edwards CR, Stewart PM, Burt D, Brett L, McIntyre MA, Sutanto WS, de Kloet ER, Monder C. Localisation of 11 beta-hydroxysteroid dehydrogenase-tissue specific protector of the mineralocorticoid receptor. Lancet. 1988;2:986-989.
6. Walker BR, Yau JL, Brett LP, Seckl JR, Monder C, Williams BC, Edwards CR. 11 Beta-hydroxysteroid dehydrogenase in vascular smooth muscle and heart: implications for cardiovascular responses to glucocorticoids. Endocrinology. 1991;129:3305-3312.
7. McEwen BS. Non-genomic and genomic effects of steroids on neural activity. Trends Pharmacol Sci. 1991;12:141-147.
8. Moss RL, Gu Q, Wong M. Estrogen: nontranscriptional signalling pathways. Rec Prog Horm Res. 1997;52:33-68.
9. Rosano CM, Sarrel PM, Poole-Wilson PA, Collins P. Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease. Lancet. 1994;342:133-136.
10. Gilligan DM, Badar DM, Panza JA, Quyyumi AA, Cannon RO 3rd. Acute vascular effects of estrogen in postmenopausal women. Circulation. 1994;90:786-791.
11. Sudhir K, Chou TM, Mullen WL, Hausmann D, Collins P, Yock PG, Chatterjee K. Mechanisms of estrogen-induced vasodilation: in vivo studies in canine coronary conductance and resistance arteries. J Am Coll Cardiol. 1995;26:807-814.
12. Wehling M. Specific, nongenomic actions of steroid hormones. Annu Rev Physiol. 1997;59:365-393.
13. Christ M, Wehling M. Cardiovascular steroid actions: swift swallows or sluggish snails? Cardiovasc Res. 1998;40:34-44.
14. Nabekura J, Oomura Y, Minami T, Mizuno Y, Fukuda A. Mechanism of the rapid effect of 17β-estradiol on medial amygdala neurons. Science. 1986;223:226-228.
15. + -antiport. Hypertension. 1995;25:117-123.
16. Wehling M, Neylon CB, Fullerton M, Bobik A, Funder JW. Nongenomic effects of aldosterone on intracellular calcium in vascular smooth muscle cells. Circ Res. 1995;76:973-979.
17. Christ M, Sippel K, Eisen C, Wehling M. Non-classical receptors for aldosterone in plasma membranes from pig kidneys. Mol Cell Endocrinol. 1994;99:R31-R34.
18. Pappas TC, Cametchu B, Watson CS. Membrane estrogen receptors identified by multiple antibody labeling and impeded-ligand binding. FASEB J. 1995;9:404-410.
19. Alexander MJ, Dobner PR, Miller MA, Bullock BP, Dorsa DM, Leeman SE. Estrogen induces neurotensin/neuromedin N mRNA in a preoptic nucleus essential for the preovulatory surge of luteinizing hormone in the rat. Endocrinology. 1989;125:2111-2117.
20. Zhou Y, Watter JJ, Dorsa DM. Estrogen rapidly induces the phosphorylation of the cAMP response element binding protein in rat brain. Endocrinology. 1996;137:2163-2166.
21. Nordeen SK, Moyer ML, Bona BJ. The coupling of multiple signal transduction pathways with steroid response mechanisms. Endocrinology. 1994;134:1723-1732.
22. Lim-Tio SS, Fuller PJ. Intracellular signaling pathways confer specificity of transactivation by mineralocorticoid and glucocorticoid receptors. Endocrinology. 1998;139:1653-1661.
23. Farhat MY, Abi-Younes S, Dingaan B, Vargas R, Ramwell PW. Estradiol increases cyclic adenosine monophosphate in rat pulmonary vascular smooth muscle cells by a nongenomic mechanism. J Pharmacol Exp Ther. 1996;276:652-657.
24. Kitazawa T, Hamada E, Kitazawa K, Gaznabi AK. Non-genomic mechanism of 17 beta-oestradiol-induced inhibition of contraction in mammalian vascular smooth muscle. J Physiol. 1997;499:497-511.
25. Christ M, Meyer C, Sippel K, Wehling M. Rapid aldosterone signalling in vascular smooth muscle cells: involvement of phospholipase C. diacylglycerol and protein kinase C α. Biochem Biophys Res Commun. 1995; 213:123-129.
26. Lee KAW, Masson N. Transcriptional regulation by CREB and its relatives. Biochem Biophys Acta. 1993;1174:221-233.
27. Kindy MS, Sonenshein GE. Regulation of oncogene expression in cultured aortic smooth muscle cells. J Biol Chem. 1986;261: 12865-12868.
28. Morin C, Asselin C, Boudreau F, Provencher PH. Transcriptional regulation of pre-pro-endothelin-1 gene by glucocorticoids in vascular smooth muscle cells. Biochem Biophys Res Commun. 1998;244:583-587.
29. Al-Dujaili EAS, Edwards CRW. The development and application of direct radioimmunoassay for plasma aldosterone using 131-I-labelled ligand-comparison of three methods. J Clin Endocrinol Metab. 1978;46: 105-113.
30. Meyer C, Christ M, Wehling M. Characterization and solubilization of novel aldosterone binding proteins in porcine liver microsomes. Eur J Biochem. 1995;229:736-740.
31. Arriza LA, Weinberger C, Cerelli G, Glaser TM, Handelin B, Housman DE, Evans RM. Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science. 1987;23:268-275.
32. Wehling M, Christ M, Theisen K. Membrane receptors for aldosterone: a novel pathway for mineralocorticoid action. Am J Physiol. 1992;263: E974-E979.
33. Clarke R, van den Berg HW, Murphy RF. Reduction of the membrane fluidity of human breast cancer cells by tamoxifen and 17β-estradiol. J Natl Cancer Inst. 1990;82:1702-1705.
34. Reddy AG, Shivaji S, Gupta PD. Effect of estradiol on the membrane fluidity of the rat vagina endothelial cells. J Steroid Biochem. 1989;33: 1229-1233.
35. 2+ currents in A7r5 vascular smooth muscle cell line Am J Physiol. 1994;266:C975-C980.
36. 2+ uptake. Circ Res. 1997;81: 242-248.
37. Shaul PW, Yuhanna IS, Sherman TS, German Z, Chen Z, Role of estrogen receptor alpha in the acute effects of estrogen on endothelial nitric oxide synthase. Circulation. 1997;96(suppl I):I-48. Abstract.
38. Dayanithi G, Tapia-Arancibia L. Rise in intracellular calcium via a nongenomic effect of allopregnanolone in fetal rat hypothalamic neurons. J Neurosci. 1996;16:130-136.
39. Lantin-Hermoso RL, Rosenfeld CR, Yuhanna IS, German Z, Chen Z, Shaul PW. Estrogen acutely stimulates nitric oxide synthase activity in fetal pulmonary artery endothelium. Am J Physiol. 1997;273: L119-L129.
40. Fiorelli G, Gori F, Frediani U, Franceschelli F, Tanini A, Tosti-Guerra C, Benvenuti S, Gennari L, Becherini L, Brandi ML. Membrane binding sites and non-genomic effects of estrogen in cultured human pre-osteoclastic cells. J Steroid Biochem Mol Biol. 1996;59: 233-240.
41. Low AM, Darby PJ, Kwan CY, Daniel EE. Effects of thapsigargin and ryanodine on vascular contractility: cross-talk between sarco-plasmatic reticulum and plasmalemma. Eur J Pharmacol. 1993;230: 53-62.
42. Zhang J, Sato M, Duzic E, Kubalak SW, Lanier SM, Webb JG. Adenylyl cyclase isoforms and vasopressin enhancement of agonist-stimulated cAMP in vascular smooth muscle cells. Am J Physiol. 1997;273: H971-H980.
43. Wang W, McChain J, Zucker I. Aldosterone reduces baroreceptor discharge in the dog. Hypertension. 1992;19:270-277.
44. Moreau D, Chardigny JM, Rochette L. Effects of aldosterone and spironolactone on the isolated perfused rat heart. Pharmacology. 1996;53: 28-36.
45. Klein K, Henk W. Klinisch-experimentelle Untersuchungen über den Einfluss von Aldosteron auf Haemodynamik und Gerinnung. Z Kreisl Forsch. 1964;52:40-53.
46. Zange J, Müller K, Gerzer R, Sippel K, Wehling M. Nongenomic effects of aldosterone on phosphocreatine levels in human calf muscle during recovery from exercise. J Clin Endocrinol Metab. 1996;81: 4296-4300.